RxSight (RXST) Amortizatization of Intangibles (2020 - 2026)
RxSight (RXST) reported Amortizatization of Intangibles of $1.9 million for Q1 2026, up 20500.0% on a YoY basis from N/an in Q1 2025, and down 78.23% quarter-over-quarter from $8.5 million in Q4 2025.
RxSight (RXST) Amortizatization of Intangibles (2020 - 2026) Analysis & Trends
RxSight has reported Amortizatization of Intangibles for 7 years, with the latest figure at $1.9 million in Q1 2026.
- For the quarter ending Q1 2026, Amortizatization of Intangibles rose 20500.0% year-over-year to $1.9 million; the trailing twelve-month figure through Mar 2026 stood at $10.4 million (up 15.63% YoY), and the FY2025 full-year result was $8.5 million, down 5.12% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $1.9 million, down from $8.5 million in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $8.5 million in Q4 2025, with the low at -$2.8 million in Q3 2023.
- Historically, Amortizatization of Intangibles has averaged $1.6 million across 5 years, with a median of $301500.0 in 2022.
- Annual changes were most pronounced in 2022 — Amortizatization of Intangibles sank 4500.0% — and 2026, when it soared 20500.0%.
- RxSight's Amortizatization of Intangibles stood at -$484000.0 in 2022, then soared by 1337.6% to $6.0 million in 2023, then sank by 56.13% to $2.6 million in 2024, then soared by 224.09% to $8.5 million in 2025, then slumped by 78.23% to $1.9 million in 2026.
- The last three Amortizatization of Intangibles figures came in at $1.9 million (Q1 2026), $8.5 million (Q4 2025), and -$9000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 422.00 Mn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 180.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 6.50 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 75.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | RxSight | 193.93 Mn | -23.95 Mn | 23.50 Mn | 1.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.85 Mn |
| Mar 31, 2026 | 1.85 Mn |
| Dec 31, 2025 | 8.52 Mn |
| Dec 31, 2025 | 8.52 Mn |
| Jun 30, 2025 | -9,000.00 |
| Jun 30, 2025 | -9,000.00 |
| Mar 31, 2025 | 9,000.00 |
| Mar 31, 2025 | 9,000.00 |
| Dec 31, 2024 | 2.63 Mn |
| Dec 31, 2024 | 2.63 Mn |
| Sep 30, 2024 | 2.77 Mn |
| Sep 30, 2024 | 2.77 Mn |
| Jun 30, 2024 | 3.55 Mn |
| Jun 30, 2024 | 3.55 Mn |
| Mar 31, 2024 | 25,000.00 |
| Mar 31, 2024 | 25,000.00 |
| Dec 31, 2023 | 5.99 Mn |
| Dec 31, 2023 | 5.99 Mn |
| Sep 30, 2023 | -2.82 Mn |
| Sep 30, 2023 | -2.82 Mn |